Congress Had a Chance to Make Your Drugs Traceable. They Didn’t Follow Through
A bipartisan bill promised greater transparency into where prescription drugs are manufactured. Then a key provision was removed
Oct 13, 2026Menu
Shedding Light on the Risks
& Benefits of Medications
Shedding Light on the Risks
& Benefits of Medications Investigating Generics
U.S. Efforts to Bring Generic Drug Manufacturing Home Ramp Up. Will It Work?
The Trump administration is seeking industry input as it pushes to increase domestic production of critical generic drugs
Oct 9, 2026
What Parents Should Know About Generic Drugs
Generics save families money and work well for most medications. But for seizure drugs, some ADHD medications, and a few other treatments, consistency can be important
Jun 24, 2026
INVESTIGATING GENERICS: Researchers Warn U.S. Can’t Guarantee Safety of Generic Drugs
In a new paper in the New England Journal of Medicine, two medical experts argue that the FDA’s inspection-based system is failing to catch quality problems and propose five reforms aimed at overhauling the generic drug market
May 19, 2026
INVESTIGATING GENERICS: FDA Records Show Drug Companies Are Skipping Safety Checks
The most common violations cited during FDA inspections involve companies failing to test ingredients, review manufacturing records, or follow basic quality control procedures
Mar 30, 2026
INVESTIGATING GENERICS: After a MedShadow Investigation, Researchers Take a Closer Look at Opioid Recalls
A newly published academic analysis finds widespread quality failures and gaps in recall notices that could affect patient safety
Feb 23, 2026
INVESTIGATING GENERICS: Push for Safer Generic Drugs Picks Up Speed on Capitol Hill
A Senate proposal to add manufacturing details to drug labels is part of a broader push for supply-chain transparency, testing, and oversight
Feb 5, 2026
Webinar: Are Any of Us Safe from Faulty Generics?
Explore the changes and incentives needed to improve generic drug quality control, supply chains, and access to safe, reliable medications.
Nov 21, 2025 Webinar: Mending the Tattered Safety Net of the FDA
Hear from whistleblowers and industry insiders working on practical solutions to improve generic drug quality, manufacturing oversight, and patient safety.
Nov 21, 2025 Webinar: How Poor Quality Generic Drugs Cause Harm
Experts explain why some generics can fail, how quality problems cause harm, and what patients can do to demand better accountability.
Nov 21, 2025
INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain
An investigation by MedShadow found that certain types of opioid medications are more likely to be recalled, and many are produced in facilities repeatedly cited for poor quality control.
Nov 3, 2025
INVESTIGATING GENERICS: Real People Share Their Struggles With Generic ADHD Medications
From strange side effects to lost scholarships, people say low-quality ADHD generics have upended their lives, confirming what studies and doctors are finding, too.
Sep 29, 2025
INVESTIGATING GENERICS: Senate Probes Drug Manufacturing Failures and Risks to U.S. Supply
At a Sept. 17th hearing, experts testified that cost-cutting, overseas labs, and weak oversight are putting Americans — especially older Americans — at risk
Sep 23, 2025
INVESTIGATING GENERICS: Two-Thirds of Americans Would Pay More for Safer Drugs
A MedShadow/Kantar survey shows most Americans support independent testing, and one in three say their generics don’t always work the same
Sep 15, 2025
INVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD Meds
Clinicians across the country say patients are reporting their medication feels less effective — or they develop new side effects — after a generic switch
Sep 3, 2025
INVESTIGATING GENERICS: The Trouble With Generic Vyvanse
Fourteen companies now make generic lisdexamfetamine, an ADHD medication, but some patients say the pills don’t work, and two manufacturers have already issued recalls
Jul 28, 2025
INVESTIGATING GENERICS: America’s Overlooked Drug Crisis
Generic drugs dominate prescriptions in the U.S. But manufacturing shortcuts and overseas oversight gaps may be putting millions at risk.
Jun 19, 2025
INVESTIGATING GENERICS: They Say Their ADHD Meds Aren’t Working. They’re Not Imagining It
Shortages, recalls, and drug variability have left people living with ADHD feeling unheard and unwell, even when they take their meds exactly as prescribed
May 30, 2025
FDA Fails in Lab Inspections of Thousands of Drug Manufacturers
An AP investigation revealed that the FDA has missed inspections for 2,000 labs since 2019, despite its own five-year mandate.
Nov 13, 2024
INVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent Trials
Generic forms of common drugs such as Lipitor and Viagra are some of the many drugs whose safety is being questioned.
Oct 28, 2024
